Skip to content
healthcare.dev

Cyproheptadine Hydrochloride

NDC 16571-805, Cyproheptadine Hydrochloride, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-805
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-805 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYPROHEPTADINE HYDROCHLORIDE4 mg/1
Package NDCNDC-11Package
16571-805-0116571080501100 TABLET in 1 BOTTLE (16571-805-01)
16571-805-10165710805101000 TABLET in 1 BOTTLE (16571-805-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5e9e983-d0d2-4f87-beae-0d853ca43983
  • NADAC price for package 16571080501

    GET /v1/drugs/nadac/16571080501
  • NADAC price for package 16571080510

    GET /v1/drugs/nadac/16571080510

Use it

Look up 16571-805 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-805 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-805. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.